Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
August 5, 2022

Acadia Pharmaceuticals receives CRL for sNDA for NUPLAZID to treat ADP

Acadia Pharmaceuticals has received a Complete Response Letter (CRL) from the US Food and Drug Administration (FDA) on its supplemental New Drug Application (sNDA) for NUPLAZID (pimavanserin).

Continue
Image: Around 30% of patients with AD experience psychosis, commonly consisting of hallucinations and delusions. Credit: Gerd Altmann from Pixabay.
July 25, 2022

QBiotics receives IND application approval for Phase II solid tumours therapy trial

Tigilanol tiglate is administered by injection directly into a solid tumour. Credit: Myriams-Fotos from Pixabay.
July 22, 2022

Bharat Biotech’s COVAXIN proven to be safe in subjects in controlled clinical trials

Image: This study was undertaken in ~184 subjects. Credit: torstensimon from Pixabay.

Contracts

July 18, 2022

Bavarian Nordic to supply additional monkeypox vaccine doses to US

Bavarian Nordic will supply 2.5 million additional doses of Jynneos vaccines for monkeypox. Credit: Willfried Wende from Pixabay.

SK Biopharmaceuticals signs licensing agreement with Eurofarma for cenobamate

WuXi XDC, AbTis sign MoU to develop ADC products

Quoin Pharmaceuticals signs license, distribution agreement with WinHealth Pharma

Deals

Deals July 21, 2022

CAMP4 Therapeutics closes $100m round to advance lead regRNA programmes

Pharmaceutical Business Review

Regeneron completes acquisition of Sanofi’s stake in Libtayo

Boehringer Ingelheim signs option to acquire Trutino Biosciences

Castle Creek Biosciences raises $112.8m to progress gene therapies

Popular

  1. Roche, Genentech sign license deal with Kiniksa for vixarelimab
  2. TransCode and MD Anderson partner to advance RNA-targeted cancer therapies
  3. US FDA grants priority review to Gamida Cell’s BLA for omidubicel
  4. Omeros gets FDA Orphan Drug Designation for PNH therapy
  5. ViiV Healthcare, Medicines Patent Pool partner to expand HIV drug access

PRESS RELEASES

Pharmaceutical Business Review
Gerresheimer Focuses on Sustainable Glass Production
Gerresheimer on Track to Deliver Record Financial Year 2022 after Solid Second Quarter
Gerresheimer on Track to Deliver Record Financial Year 2022 after Solid Second Quarter
Pharmaceutical Business Review
Gerresheimer Awarded EcoVadis Gold for Sustainable Corporate Management for the First Time
Pharmaceutical Business Review
NSF is Expanding its Most Popular Virtual, Instructor-Led Pharmaceutical Courses to Run at Times Convenient for North American Delegates
Customer Need Leads to New Denny Bros Product
Customer Need Leads to New Denny Bros Product

Suppliers

Whitepapers

Deeper Insight into the Pyrolysis of Acetylsalicylic Acid by Means of Kinetic Analysis
Deeper Insight into the Pyrolysis of Acetylsalicylic Acid by Means of Kinetic Analysis
Affinity Tag Coating Enables Reliable Detection of Antigen-Specific B Cells in Immunospot Assays
Affinity Tag Coating Enables Reliable Detection of Antigen-Specific B Cells in Immunospot Assays
Deuterium-Containing Building Blocks for Drug Design
Deuterium-Containing Building Blocks for Drug Design